In a study of Coradini et al (2001) on the contribution of VEGF to the Nottingham prognostic index, VEGF was of borderline significance for RFS in 226 node-negative patients who were not treated with adjuvant systemic therapy.
← all excerpts
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
1
—
—